Wegener's granulomatosis: Epidemiological and clinical features in a South Australian study

Internal Medicine Journal

Volumn 38, Issue 10, 2008, Pages 776-780

  Hissaria, P ^a   Cai, F Z J ^b   Ahern, M ^b,c   Smith, M ^b,c   Gillis, D ^a   Roberts Thomson, P ^b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Epidemiology; Outcome; Wegener's granulomatosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; AUSTRALIA; CLINICAL FEATURE; DEATH; DEMOGRAPHY; FEMALE; HUMAN; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SOUTH AUSTRALIA; SURVIVAL RATE; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 55349145989     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01694.x     Document Type: Article

References (13)

1. Hoffman G, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998 41 : 1521 37.
2. Kondingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000 43 : 2481 7.
3. O'Donnell JL, Stevanovic VR, Frampton C, Stamp LK, Chapman PT. Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Intern Med J 2007 37 : 242 6.
4. Leavitt R, Fauci A, Bloch DA, Miche B, Hunder G, Arend W et al. The American college of rheumatology 1990 criteria for classification of Wegener's granulomatosis. Arthritis Rheum 1990 33 : 1101 7.
5. Abdou N, Kullman G, Hoffman GS, Sharp GC, Specks U, McDonald T et al. Wegener's granulomatosis: survey of 701 patients in North America. Changes in the outcome in 1990s. J Rheumatol 2002 29 : 309 16.
6. Gibson A, Stamp LK, Chapman PT, O'Donnell JL. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology 2006 45 : 624 8.
7. Reinhold-Keller E, Beuge N, Latza U, De Groot K, Rudert H, Nolle B et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Arthritis Rheum 2000 43 : 1021 32.
8. Cotch M, Hoffman G, Yerg D, Kaufman G, Targonski P, Kaslow R. The epidemiology of Wegener's granulomatosis: estimates of the five year period prevalence, annual mortality and geographic disease distribution from population-based data sources. Arthritis Rheum 1996 39 : 87 92.
9. de Leeuw K, Sanders J-S, Stegeman C, Smit A, Kallenberg CG, Bijl M. Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 2005 64 : 753 9.
10. Swets BP, Brouwer AJ, Tervaert WC. Patients with systemic vasculitis have increased levels of autoantibodies against oxidised LDL. Clin Exp Immunol 2001 124 : 163 7.
11. Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's Granulomatosis. Rheumatology 2002 41 : 572 81.
12. Luqmani RA, Bacon PA, Beaman M, Scott DG, Emery P, Lee SJ et al. Classical versus non-renal Wegener's granulomatosis. Q J Med 1994 87 : 161 7.
13. Exley AR, Carruthers DM, Luqmani RA, Kitas GD, Gordon C, Janssen BA et al. Damage occurs early in systemic vasculitis and is an index of outcome. Q J Med 1997 90 : 391 9.